Literature DB >> 14684216

Primary malignant mesothelioma of the liver: MR imaging findings.

Polytimi Leonardou1, Richard C Semelka, Masayuki Kanematsu, Larissa Braga, John T Woosley.   

Abstract

We report the MR imaging findings of a primary malignant mesothelioma of the liver arising from Glisson's capsule. A 54-year-old woman, presenting with acute abdominal pain and a large liver mass previously shown on CT, underwent MR imaging to characterize the lesion. The tumor was a greater than 12 cm tumor located in the right lobe of the liver, which was sharply marginated, with heterogeneous internal signal, septations and central necrosis. The tumor was considered a hepatocellular carcinoma. The diagnosis of malignant mesothelioma was established by immunohistochemical staining and electron microscopy of the resected tumor.

Entities:  

Mesh:

Year:  2003        PMID: 14684216     DOI: 10.1016/s0730-725x(03)00197-8

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  15 in total

Review 1.  Localized intrapancreatic malignant mesothelioma: a rare entity that may be confused with other pancreatic neoplasms.

Authors:  Rosanny Espinal-Witter; Elliot L Servais; David S Klimstra; Michael D Lieberman; Rhonda K Yantiss
Journal:  Virchows Arch       Date:  2010-02-11       Impact factor: 4.064

Review 2.  An unusual liver mass: primary malignant mesothelioma of the liver : CT and MRI findings and literature review.

Authors:  Asli Serter; Nur Buyukpinarbasili; Oguzhan Karatepe; Ercan Kocakoc
Journal:  Jpn J Radiol       Date:  2014-12-18       Impact factor: 2.374

3.  Lymph node dissection in primary intrahepatic malignant mesothelioma: case report and implications for diagnosis and therapy.

Authors:  Bettina M Buchholz; Ines Gütgemann; Hans-Peter Fischer; Marcus Gorschlüter; Andreas Türler; Jörg C Kalff; Andreas Hirner; Jens Standop
Journal:  Langenbecks Arch Surg       Date:  2009-03-12       Impact factor: 3.445

4.  Primary intrahepatic malignant mesothelioma of epithelioid type.

Authors:  Ines Gütgemann; Jens Standop; Hans-Peter Fischer
Journal:  Virchows Arch       Date:  2006-03-16       Impact factor: 4.064

5.  Current status of malignant mesothelioma with liver involvement in China: A brief report and review of the literature.

Authors:  Di Zhou; Zhiwei Quan; Jiandong Wang
Journal:  Intractable Rare Dis Res       Date:  2018-05

6.  Primary localized malignant biphasic mesothelioma of the liver in a patient with asbestosis.

Authors:  Motoko Sasaki; Ichiro Araki; Toshiaki Yasui; Masaru Kinoshita; Keita Itatsu; Takayuki Nojima; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

Review 7.  Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel.

Authors:  Alberto M Marchevsky; Andras Khoor; Ann E Walts; Andrew G Nicholson; Yu Zhi Zhang; Victor Roggli; John Carney; Anja C Roden; Henry D Tazelaar; Brandon T Larsen; Nolwenn LeStang; Lucian R Chirieac; Sonja Klebe; Ming-Sound Tsao; Marc De Perrot; Andrew Pierre; David M Hwang; Yin P Hung; Mari Mino-Kenudson; William Travis; Jennifer Sauter; Mary Beth Beasley; Françoise Galateau-Sallé
Journal:  Mod Pathol       Date:  2019-09-04       Impact factor: 7.842

8.  Primary Malignant Mesothelioma of the Liver: Case Report and Review of the Literature.

Authors:  Subash Ghimire; Nilisha Regmi; Tsujung Yang; Harshil Shah; Ukorn Srivatana; Ashit Sarker; Hafiz Khan
Journal:  Eur J Case Rep Intern Med       Date:  2020-12-18

9.  Primary intrahepatic malignant epithelioid mesothelioma.

Authors:  Iraklis Perysinakis; Alexander M Nixon; Ioannis Spyridakis; George Kakiopoulos; Charalampos Zorzos; Ilias Margaris
Journal:  Int J Surg Case Rep       Date:  2014-11-13

10.  Primary intrahepatic malignant mesothelioma with multiple lymphadenopathies due to non-tuberculous mycobacteria: A case report and review of the literature.

Authors:  Noriko Inagaki; Kayoko Kibata; Takeshi Tamaki; Toshiki Shimizu; Shosaku Nomura
Journal:  Oncol Lett       Date:  2013-07-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.